Literature DB >> 14592488

Synthesis of novel fluorescent probes for the molecular chaperone Hsp90.

Laura Llauger-Bufi1, Sara J Felts, Henri Huezo, Neal Rosen, Gabriela Chiosis.   

Abstract

Heat shock protein 90 (Hsp90) is a molecular chaperone necessary for maintaining oncogenic transformation. There is substantial interest in developing novel agents that bind to the N-terminal of the chaperone. Here we report the synthesis and characterization of two fluorescent Hsp90 inhibitors and probe their use in an Hsp90 fluorescent polarization assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592488     DOI: 10.1016/j.bmcl.2003.08.065

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Design of a fluorescence polarization assay platform for the study of human Hsp70.

Authors:  Yanlong Kang; Tony Taldone; Cristina C Clement; Sheara W Fewell; Julia Aguirre; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2008-05-16       Impact factor: 2.823

2.  A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues.

Authors:  Lata T Gooljarsingh; Christine Fernandes; Kang Yan; Hong Zhang; Michael Grooms; Kyung Johanson; Robert H Sinnamon; Robert B Kirkpatrick; John Kerrigan; Tia Lewis; Marc Arnone; Alastair J King; Zhihong Lai; Robert A Copeland; Peter J Tummino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

Review 3.  Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.

Authors:  Laura J Blair; Jonathan J Sabbagh; Chad A Dickey
Journal:  Expert Opin Ther Targets       Date:  2014-07-29       Impact factor: 6.902

4.  Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy.

Authors:  Tony Taldone; Erica M Gomes-DaGama; Hongliang Zong; Siddhartha Sen; Mary L Alpaugh; Danuta Zatorska; Raul Alonso-Sabadell; Monica L Guzman; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2011-07-14       Impact factor: 2.823

5.  Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Authors:  Thota Ganesh; Jaeki Min; Pahk Thepchatri; Yuhong Du; Lian Li; Iestyn Lewis; Larry Wilson; Haian Fu; Gabriela Chiosis; Raymond Dingledine; Dennis Liotta; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem       Date:  2008-05-27       Impact factor: 3.641

6.  Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.

Authors:  Tony Taldone; Pallav D Patel; Maulik Patel; Hardik J Patel; Christopher E Evans; Anna Rodina; Stefan Ochiana; Smit K Shah; Mohammad Uddin; Daniel Gewirth; Gabriela Chiosis
Journal:  J Med Chem       Date:  2013-08-21       Impact factor: 7.446

7.  Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity.

Authors:  Dora Posfai; Amber L Eubanks; Allison I Keim; Kuan-Yi Lu; Grace Z Wang; Philip F Hughes; Nobutaka Kato; Timothy A Haystead; Emily R Derbyshire
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

8.  Resorcinol-Based Grp94-Selective Inhibitors.

Authors:  Anuj Khandelwal; Vincent M Crowley; Brian S J Blagg
Journal:  ACS Med Chem Lett       Date:  2017-09-01       Impact factor: 4.345

9.  Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins.

Authors:  Anh-Nhan Pham; Jeffrey Wang; Jialong Fang; Xin Gao; Yilong Zhang; Paul E Blower; Wolfgang Sadée; Ying Huang
Journal:  Pharm Res       Date:  2008-12-10       Impact factor: 4.200

Review 10.  Cancer and virus leads by HTS, chemical design and SEA data mining.

Authors:  Pahk Thepchatri; Jaeki Min; Thota Ganesh; Yuhong Du; Iestyn Lewis; Serdar Kurtkaya; Andrew Prussia; Lian Li; Blossom Sneed; Richard K Plemper; Haian Fu; Dennis C Liotta; James P Snyder; Raymond Dingledine; Aiming Sun
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.